Literature DB >> 25770172

Clinical predictors of mortality in patients with Ebola virus disease.

Moumié Barry1, Abdoulaye Touré2, Fodé Amara Traoré3, Fodé-Bangaly Sako1, Djibril Sylla4, Dimai Ouo Kpamy1, Elhadj Ibrahima Bah1, M'Mah Bangoura1, Marc Poncin5, Sakoba Keita6, Thierno Mamadou Tounkara2, Mohamed Cisse2, Philippe Vanhems7.   

Abstract

In an observational cohort study including 89 Ebola patients, predictive factors of death were analyzed. The crude mortality rate was 43.8%. Myalgia (adjusted odds ratio [OR], 4.04; P = .02), hemorrrhage (adjusted OR, 3.5; P = .02), and difficulty breathing (adjusted OR, 5.75; P = .01) were independently associated with death.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Ebola virus disease; hemorrhagic fever; mortality

Mesh：

Year:  2015        PMID： 25770172     DOI： 10.1093/cid/civ202

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  22 in total

Review 1.  Insights from clinical research completed during the west Africa Ebola virus disease epidemic.

Authors:  Amanda Rojek; Peter Horby; Jake Dunning
Journal:  Lancet Infect Dis       Date:  2017-04-28       Impact factor: 25.071

2.  Development of a Prediction Model for Ebola Virus Disease: A Retrospective Study in Nzérékoré Ebola Treatment Center, Guinea.

Authors:  Paul Loubet; Romain Palich; Richard Kojan; Olivier Peyrouset; Christine Danel; Sarala Nicholas; Mamoudou Conde; Klaudia Porten; Augustin Augier; Yazdan Yazdanpanah
Journal:  Am J Trop Med Hyg       Date:  2016-10-10       Impact factor: 2.345

3.  The predictor of mortality outcome in adult patients with Ebola virus disease during the 2014-2015 outbreak in Guinea.

Authors:  M S Cherif; N Koonrungsesomboon; M P Diallo; E Le Gall; D Kassé; F Cherif; A Koné; M Diakité; F Camara; N Magassouba
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-25       Impact factor: 3.267

4.  Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea.

Authors:  Marie-Astrid Vernet; Stéphanie Reynard; Alexandra Fizet; Justine Schaeffer; Delphine Pannetier; Jeremie Guedj; Max Rives; Nadia Georges; Nathalie Garcia-Bonnet; Aboubacar I Sylla; Péma Grovogui; Jean-Yves Kerherve; Christophe Savio; Sylvie Savio-Coste; Marie-Laure de Séverac; Philippe Zloczewski; Sandrine Linares; Souley Harouna; Bing M'Lebing Abdoul; Frederic Petitjean; Nenefing Samake; Susan Shepherd; Moumouni Kinda; Fara Roger Koundouno; Ludovic Joxe; Mathieu Mateo; Patrick Lecine; Audrey Page; Tang Maleki Tchamdja; Matthieu Schoenhals; Solenne Barbe; Bernard Simon; Tuan Tran-Minh; Christophe Longuet; François L'Hériteau; Sylvain Baize
Journal:  JCI Insight       Date:  2017-03-23

5.  Clinical Management of Ebola Virus Disease in the United States and Europe.

Authors:  Timothy M Uyeki; Aneesh K Mehta; Richard T Davey; Allison M Liddell; Timo Wolf; Pauline Vetter; Stefan Schmiedel; Thomas Grünewald; Michael Jacobs; Jose R Arribas; Laura Evans; Angela L Hewlett; Arne B Brantsaeter; Giuseppe Ippolito; Christophe Rapp; Andy I M Hoepelman; Julie Gutman
Journal:  N Engl J Med       Date:  2016-02-18       Impact factor: 91.245

6.  Development and Evaluation of a Rapid and Sensitive EBOV-RPA Test for Rapid Diagnosis of Ebola Virus Disease.

Authors:  Mingjuan Yang; Yuehua Ke; Xuesong Wang; Hang Ren; Wei Liu; Huijun Lu; Wenyi Zhang; Shiwei Liu; Guohui Chang; Shuguang Tian; Lihua Wang; Liuyu Huang; Chao Liu; Ruifu Yang; Zeliang Chen
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

Review 7.  Ebola virus disease.

Authors:  Shevin T Jacob; Ian Crozier; William A Fischer; Angela Hewlett; Colleen S Kraft; Marc-Antoine de La Vega; Moses J Soka; Victoria Wahl; Anthony Griffiths; Laura Bollinger; Jens H Kuhn
Journal:  Nat Rev Dis Primers       Date:  2020-02-20       Impact factor: 52.329

8.  Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial.

Authors:  Jake Dunning; Foday Sahr; Amanda Rojek; Fiona Gannon; Gail Carson; Baimba Idriss; Thomas Massaquoi; Regina Gandi; Sebatu Joseph; Hassan K Osman; Timothy J G Brooks; Andrew J H Simpson; Ian Goodfellow; Lucy Thorne; Armando Arias; Laura Merson; Lyndsey Castle; Rebecca Howell-Jones; Raul Pardinaz-Solis; Benjamin Hope-Gill; Mauricio Ferri; Jennifer Grove; Mark Kowalski; Kasia Stepniewska; Trudie Lang; John Whitehead; Piero Olliaro; Mohammed Samai; Peter W Horby
Journal:  PLoS Med       Date:  2016-04-19       Impact factor: 11.069

9.  Ebola Virus Infection: Overview and Update on Prevention and Treatment.

Authors:  Miguel J Martínez; Abdulbaset M Salim; Juan C Hurtado; Paul E Kilgore
Journal:  Infect Dis Ther       Date:  2015-09-12

10.  Experimental Treatment of Ebola Virus Disease with Brincidofovir.

Authors:  Jake Dunning; Stephen B Kennedy; Annick Antierens; John Whitehead; Iza Ciglenecki; Gail Carson; Rupa Kanapathipillai; Lyndsey Castle; Rebecca Howell-Jones; Raul Pardinaz-Solis; Jennifer Grove; Janet Scott; Trudie Lang; Piero Olliaro; Peter W Horby
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.